Driehaus Capital Management LLC

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 938206 Chicago, IL

Position in PRAX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$321,079,679

+$15,248,877 QoQ

Shares Held

959,048

+1.0% QoQ

Ownership

3.43%

of shares outstanding

% of Portfolio

1.87%

of 13F equity value

Holder Rank

#12

of 308 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 85% Shared 0% None 15%

Healthcare · as of Jun 30, 2026

Driehaus Capital Management LLC holds $3,602,052,293 across 59 Biotechnology names. PRAX ranks #2 (8.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DFTX	Definium Therapeutics, Inc.	6,845,276	$322,001,783
2	PRAX	Praxis Precision Medicines, Inc. This page	959,048	$321,079,679
3	XENE	Xenon Pharmaceuticals Inc.	4,418,557	$266,704,100
4	SYRE	Spyre Therapeutics, Inc.	2,799,166	$248,509,957
5	CRNX	Crinetics Pharmaceuticals, Inc.	6,463,551	$241,866,078
6	APGE	Apogee Therapeutics, Inc.	1,740,101	$230,963,605
7	EWTX	Edgewise Therapeutics, Inc.	4,728,623	$192,123,952
8	SEPN	Septerna, Inc.	4,433,058	$148,463,112

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$321,079,679	959,048	+1.0%	Shares	Sole	2026-08-14
2026-03-31	$305,830,802	949,225	+1.7%	Shares	Sole	2026-05-15
2025-12-31	$275,010,399	933,061	+86.4%	Shares	Sole	2026-02-17
2025-09-30	$26,529,203	500,551	-5.7%	Shares	Sole	2025-11-14
2025-06-30	$22,328,045	530,988	+10.3%	Shares	Sole	2025-08-14
2025-03-31	$18,238,116	481,598	+192.0%	Shares	Sole	2025-05-15
2024-12-31	$12,691,627	164,912	-0.7%	Shares	Sole	2025-02-14
2024-09-30	$9,554,862	166,056	-37.3%	Shares	Sole	2024-11-14
2024-06-30	$10,947,495	264,688	-0.7%	Shares	Sole	2024-08-15
2024-03-31	$16,261,585	266,496	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.